ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.536,73
-0,56%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) News

MGTA Magenta Therapeutics Inc

11,1936
0,00 (0,00%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Magenta Therapeutics Inc MGTA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 11,1936 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
11,1936 11,1936
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.4.202422:10EDGAR2Form ARS - Annual Report to Security Holders
11.4.202422:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11.4.202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
02.4.202400:34EDGAR2Form SC 13D/A - General statement of acquisition of..
02.4.202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.3.202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
21.3.202422:02EDGAR2Form S-1/A - General form for registration of securities..
21.3.202421:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21.3.202421:04EDGAR2Form 8-K - Current report
14.2.202422:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202422:52EDGAR2Form S-1/A - General form for registration of securities..
02.2.202422:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31.1.202418:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26.1.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202423:26EDGAR2Form SC 13D/A - General statement of acquisition of..
22.1.202413:34EDGAR2Form 8-K - Current report
08.1.202414:02EDGAR2Form 8-K - Current report
21.12.202323:08EDGAR2Form S-1/A - General form for registration of securities..
21.12.202322:16EDGAR2Form 8-K - Current report
09.11.202322:09EDGAR2Form 8-K - Current report
25.10.202322:15EDGAR2Form 8-K - Current report
04.10.202322:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
04.10.202322:20EDGAR2Form S-3 - Registration statement under Securities Act of..
25.9.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.9.202322:34EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21.9.202322:32EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21.9.202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21.9.202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21.9.202303:50EDGAR2Form 8-K/A - Current report: [Amend]
14.9.202303:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202303:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.9.202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202303:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202303:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202302:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.9.202302:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.9.202302:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.9.202302:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.9.202302:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
12.9.202322:05EDGAR2Form 8-K - Current report
08.9.202323:19EDGAR2Form 8-K - Current report
31.8.202315:00EDGAR2Form 425 - Prospectuses and communications, business..
03.8.202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202322:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17.7.202315:30EDGAR2Form S-4/A - Registration of securities, business..

Kürzlich von Ihnen besucht

NASDAQ
MGTA
Magenta Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten